PHARMASUM THERAPEUTICS AS

0349 OSLO

Finances

Share Ownership

Return on Equity

246,01 %

Current Ratio

1,41

Debt-to-Equity Ratio

−1,49

Key figures (NOK)	2022	2021	2020	2019
Revenue	1 520 000	538 000	0	390 000
Net Income	−2 187 000	−3 248 000	−612 000	−2 238 000
Total Assets	1 424 000	3 471 000	5 206 000	879 000
Total Equity	−889 000	1 298 000	2 908 000	−7 655 000

Income (NOK)	2022	2021	2020	2019
Revenue	1 520 000	538 000	0	390 000
Expenditure	3 706 000	3 777 000	518 000	2 478 000
Operating Profit	−2 186 000	−3 239 000	−518 000	−2 088 000
Financial Income	15 000	16 000	2 000	9 000
Financial Costs	17 000	25 000	96 000	159 000
Financial Balance	−2 000	−9 000	−94 000	−150 000
Earnings Before Tax	−2 187 000	−3 248 000	−612 000	−2 238 000
Tax	0	0	0	0
Net Income	−2 187 000	−3 248 000	−612 000	−2 238 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	29 000	0	0	0
Total Current Assets	1 395 000	3 471 000	5 206 000	879 000
Total Assets	1 424 000	3 471 000	5 206 000	879 000
Total Retained Equity	−1 176 000	0	0	−25 560 000
Total Equity	−889 000	1 298 000	2 908 000	−7 655 000
Total Long-Term Debt	1 323 000	1 323 000	0	0
Total Current Debt	990 000	850 000	2 298 000	8 534 000
Total Equity and Debt	1 424 000	3 471 000	5 206 000	879 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	0	0	0	0
Other Income	1 520 000	538 000	0	390 000
Revenue	1 520 000	538 000	0	390 000
Cost of Goods Sold	0	0	0	0
Salary Costs	1 982 000	1 668 000	68 000	494 000
Depreciation	10 000	0	0	1 100 000
Impairment	0	0	0	0
Expenditure	3 706 000	3 777 000	518 000	2 478 000
Operating Profit	−2 186 000	−3 239 000	−518 000	−2 088 000
Financial Income	15 000	16 000	2 000	9 000
Financial Costs	17 000	25 000	96 000	159 000
Financial Balance	−2 000	−9 000	−94 000	−150 000
Dividends	0	0	0	0
Net Income	−2 187 000	−3 248 000	−612 000	−2 238 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	0
Real Eastate	0	0	0	0
Machinery and Plant Facilities	29 000	0	0	0
Fixtures	0	0	0	0
Total Tangible Assets	29 000	0	0	0
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	29 000	0	0	0
Stock	0	0	0	0
Total Investments	0	0	0	0
Cash, Bank	602 000	2 917 000	4 865 000	684 000
Total Current Assets	1 395 000	3 471 000	5 206 000	879 000
Total Assets	1 424 000	3 471 000	5 206 000	879 000
Total Equity	−889 000	1 298 000	2 908 000	−7 655 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	1 323 000	1 323 000	0	0
Creditors	367 000	253 000	1 493 000	2 377 000
Unpaid Taxes	129 000	129 000	0	0
Dividends	0	0	0	0
Other Current Debt	494 000	467 000	806 000	6 157 000
Total Current Debt	990 000	850 000	2 298 000	8 534 000
Total Equity and Debt	1 424 000	3 471 000	5 206 000	879 000

Financial indicators	2022	2021	2020	2019
Return on Equity	246,01 %	−250,23 %	−21,05 %	29,24 %
Debt-to-Equity Ratio	−1,49	1,02	0	−0
Operating Profit Margin	−143,82 %	−602,04 %	-	−535,38 %
Current Ratio	1,41	4,08	2,27	0,1
Quick Ratio	1,41	4,08	2,27	0,1
Equity Ratio	−0,62	0,37	0,56	−8,71
Gross Profit Margin	100 %	100 %	-	100 %